Refine by
Point Of Care Tests Articles & Analysis
50 news found
” Protheragen’s rare disease diagnostic development services cover in vitro diagnostic (IVD) product development, point-of-care test (POCT) development, laboratory animal models, and companion diagnostic development. ...
In addition, PDMS is the most widely used material for the manufacture of microfluidic devices, which are an important technology for the development of systems for drug delivery, DNA sequencing, clinical diagnostics, point-of-care testing, and chemical synthesis. The materials used in these systems should be biocompatible, optically transparent, ...
Medical Equipment Pump Solutions Industry Overview IVD, which stands for in vitro diagnostics, refers to products that conduct testing on samples taken from the human body (such as blood, body fluids, and tissues) outside of the body in order to obtain clinical diagnostic information. The IVD industry is subdivided into various sectors including immunodiagnostics, clinical ...
With the increasing demand for diagnostics in resource-limited settings, lateral flow assays (LFAs) for nucleic acid testing are receiving increasing attention due to their low cost and ease of use. They have also shown great potential in point-of-care testing (POCT). Currently, target gene amplification has been widely used in ...
Program, designed and administered by the Massachusetts Life Sciences Center, which supports projects focused on two core areas: accelerating the development of at-home or point-of-care testing methods that are simpler and faster, and new and innovative solutions that address existing supply chain bottlenecks. ...
LightDeck’s planar waveguide technology optimizes laser activated fluorescence and microfluidics to provide point of care cartridge-based testing without compromise, enabling reference lab-quality results in minutes with inexpensive, quantitative, and easy-to- use functionality. ...
HiberGene Diagnostics, the leading manufacturer of molecular diagnostics products in Ireland, is pleased to announce that it will supply its innovative point-of-care (POC) and near-patient testing solutions directly to healthcare providers in the UK and Ireland. These high-quality testing solutions cover infectious and ...
We’d like to thank The Body Agency and Visby Medical for working with Chiricahua to bring point of care testing and treatment directly to women who need it ...
Virusight Diagnostic, a world leader in combining artificial intelligence software and spectral technology today announced the results of a major clinical study that found its ultra-rapid, point of care Pathogens Diagnostic solution consistently delivers 96.3% accuracy when compared to the gold standard RT-PCR. ...
The AscencioDx represents a new generation of point-of-care molecular diagnostic testing that enables highly accurate results in about 30 minutes. ...
There are numerous ways to provide quality diagnosis and preventative care. One of them is by investing in portable scanners, adopting huge benefits for improved healthcare procedures. ...
“LightDeck is revolutionizing testing at the point of care – whether it’s in a clinic or emergency room, or even a retail pharmacy. This year we aim to launch our first ultra-rapid COVID-19 test products, followed by additional in-vitro diagnostic panels, including inflammation, triage, and hormone ...
“We believe the LightDeck analyzer capabilities to measure a panel of inflammation markers in minutes should allow improved patient care promptly upon arrival to the emergency room or clinic.” The LightDeck Analyzer leverages planar waveguide technology, which can enable quantitative, highly sensitive and specific tests for dozens of biomarkers on a ...
In the fourth quarter of 2021, we sold approximately 65 million QuickVue® COVID-19 antigen tests and over 4 million Sofia® SARS antigen tests – the highest quarterly sales volume for tests for Quidel. We continue to work diligently to meet demand from government, retail, employers and distributors for our QuickVue At-Home OTC ...
TearLab Corporation, a global ophthalmic diagnostics company marketing point-of-care laboratory testing, today announced that Adam Szaronos has been appointed President and Chief Executive Officer by the company's Board of Directors, effective immediately. ...
BySOFIE
Tests in the field, specifically at Brussels Airport, started last month. ...
Rapid and accurate point-of-care results create a better workflow, and can play a pivotal role in preventing the misuse of antibiotics by enabling clinicians to select the most effective treatment for the condition. ...
The initial EUA submission will claim effectiveness for administration by a licensed medical professional in a point-of-care setting, including physician offices, hospital emergency rooms, urgent care clinics, mobile testing sites, colleges and universities, as well as workspaces and other sites deemed appropriate by the ...
We’re able to illuminate the sample faster without the additional process steps that are typically required.” Preceding point-of-care diagnostic systems have had trouble balancing accuracy and cost. “The trick is to meet the performance requirements of your central laboratory testing while still having the affordability and ...
Lumos Diagnostics (ASX: LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced that Health Canada has granted Interim Order authorization for the Lumos CoviDx™ SARS-CoV-2 Rapid Antigen Test. ...